BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
BOSTON SCIENTIFIC CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$45.05+0.66 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $66.44B
- P/E (TTM)
- 18.2
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
92.1%
1.34B of 1.45B shares
Institutional holders
1,474
147 new, 326 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
10 buys · 9 sales
Net sold $14.31M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 113,006,671 | 7.60% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 111,127,205 | 7.47% | 13G (passive) | Mar 31, 2026 |
| FMR LLC | 110,320,938 | 7.50% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BSX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 129,680,916 | 8.95% | $5.53B | −2,141,121 | 0.08% |
| Vanguard Capital Management LLC | 97,087,553 | 6.70% | $4.14B | +675,985 | 0.09% |
| State Street Corp | 70,111,196 | 4.84% | $2.99B | +2,124,349 | 0.09% |
| Primecap Management Co/Ca/ | 50,520,914 | 3.49% | $2.16B | +17,991,140 | 1.28% |
| FMR LLC | 45,702,845 | 3.15% | $1.95B | −28,523,550 | 0.08% |
| Geode Capital Management, LLC | 33,440,102 | 2.31% | $1.42B | +154,345 | 0.08% |
| Vanguard Portfolio Management LLC | 29,792,794 | 2.06% | $1.27B | −3,417 | 0.06% |
| D. E. Shaw & Co., Inc. | 25,457,409 | 1.76% | $1.09B | +1,145,057 | 0.52% |
| Massachusetts Financial Services Co /Ma/ | 24,859,191 | 1.72% | $1.50B | +13,862,619 | 0.48% |
| JPMorgan Chase & Co | 23,907,838 | 1.65% | $1.04B | −9,442,319 | 0.06% |
| Arrowstreet Capital, Limited Partnership | 23,293,913 | 1.61% | $994.18M | +9,402,245 | 0.44% |
| Norges Bank | 21,170,029 | 1.46% | $903.54M | New | 0.09% |
| Two Sigma Investments, LP | 19,359,023 | 1.34% | $826.24M | +9,947,792 | 0.60% |
| Morgan Stanley | 18,947,147 | 1.31% | $808.66M | −3,319,517 | 0.04% |
| Jupiter Topco LLC | 18,822,853 | 1.30% | $803.36M | New | 0.33% |
| Bollard Group LLC | 18,420,720 | 1.27% | $786.20K | −111,453 | 23.93% |
| Goldman Sachs Group Inc | 16,954,342 | 1.17% | $723.61M | −1,937,282 | 0.06% |
| Capital World Investors | 16,812,257 | 1.16% | $717.60M | +1,502,519 | 0.08% |
| UBS Group AG | 16,352,420 | 1.13% | $697.92M | +1,527,758 | 0.09% |
| Wellington Management Group Llp | 15,301,828 | 1.06% | $653.08M | −3,531,578 | 0.11% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,474 | 1.34B | 92.1% | 147 / 587 | 614 / 326 | 206M | 198M |
| Q1 2026 | 1,679 | 1.34B | 92.8% | 196 / 677 | 637 / 280 | 313M | 197M |
| Q4 2025 | 1,790 | 1.37B | 94.6% | 235 / 668 | 692 / 129 | 130M | 129M |
| Q3 2025 | 1,716 | 1.38B | 95.1% | 179 / 768 | 559 / 131 | 125M | 107M |
| Q2 2025 | 1,694 | 1.36B | 93.9% | 156 / 754 | 552 / 91 | 91M | 78M |
| Q1 2025 | 1,648 | 1.35B | 93.2% | 231 / 668 | 555 / 74 | 88M | 68M |
| Q4 2024 | 1,519 | 1.34B | 92.7% | 220 / 618 | 492 / 84 | 79M | 83M |
| Q3 2024 | 1,402 | 1.35B | 93.2% | 166 / 565 | 478 / 76 | 179M | 59M |
| Q2 2024 | 1,323 | 1.36B | 93.7% | 171 / 554 | 419 / 53 | 74M | 98M |
| Q1 2024 | 1,226 | 1.40B | 96.3% | 158 / 441 | 452 / 70 | 90M | 68M |
| Q4 2023 | 1,151 | 1.39B | 95.7% | 178 / 442 | 377 / 68 | 122M | 73M |
| Q3 2023 | 1,059 | 1.34B | 92.4% | 99 / 440 | 353 / 95 | 82M | 63M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BSX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 47,181,284 | 3.26% | $2.01B | 0.09% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 38,518,788 | 2.66% | $1.64B | 0.10% | Jun 30, 2026 |
| Vanguard Primecap Fund | 30,831,039 | 2.13% | $1.32B | 1.37% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 20,445,345 | 1.41% | $872.61M | 0.10% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 18,978,237 | 1.31% | $916.84M | 0.11% | May 31, 2026 |
| Growth Fund of America | 13,027,839 | 0.90% | $629.37M | 0.17% | May 31, 2026 |
| Vanguard Health Care Fund | 12,474,112 | 0.86% | $582.92M | 1.53% | Jul 31, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 10,500,647 | 0.72% | $448.17M | 1.10% | Jun 30, 2026 |
| Vanguard Growth Index Fund | 9,210,339 | 0.64% | $393.10M | 0.10% | Jun 30, 2026 |
| Vanguard Capital Opportunity Fund | 8,820,206 | 0.61% | $376.45M | 1.15% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 8,069,042 | 0.56% | $344.39M | 0.10% | Jun 30, 2026 |
| Vanguard Value Index Fund | 7,086,757 | 0.49% | $302.46M | 0.12% | Jun 30, 2026 |
| AMCAP Fund | 6,913,184 | 0.48% | $333.98M | 0.34% | May 31, 2026 |
| Janus Henderson Enterprise Fund | 6,658,970 | 0.46% | $284.20M | 1.27% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 6,238,651 | 0.43% | $301.39M | 0.12% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael F. Mahoney | Chairman, President & CEO, Director | 1,612,143 | 0.11% | Aug 5, 2026 |
| Padraig Andrew O'Connor | EVP, Global Operations | 7,892 | 0.00% | Sep 3, 2026 |
| Emily Woodworth | SVP, Global Controller and CAO | 6,053 | 0.00% | Aug 12, 2026 |
| Jonathan Monson | EVP and CFO | 48,971 | 0.00% | Aug 11, 2026 |
| Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 283,339 | 0.02% | Aug 3, 2026 |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | 78,122 | 0.01% | May 4, 2026 |
| Vance R. Brown | EVP, GC and Corp. Secretary | 55,134 | 0.00% | Feb 18, 2026 |
| Miriam O'Sullivan | SVP, Chief HR Officer | 19,324 | 0.00% | Feb 18, 2026 |
| John Bradley Sorenson | EVP, Global Operations | 18,705 | 0.00% | May 6, 2025 |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 50,766 | 0.00% | Feb 25, 2025 |
| Daniel J. Brennan | EVP and CFO | 283,658 | 0.02% | Feb 19, 2025 |
| Wendy Carruthers | EVP, Human Resources | 29,308 | 0.00% | Dec 4, 2024 |
| Susan E. Morano | Director | 13,784 | 0.00% | Aug 26, 2026 |
| David C. Habiger | Director | 17,160 | 0.00% | Aug 7, 2026 |
| Edward J. Ludwig | Director | 30,359 | 0.00% | Aug 3, 2026 |
| Cheryl Pegus | Director | 1,770 | 0.00% | May 21, 2026 |
| Christophe Pierre Weber | Director | 2,646 | 0.00% | May 11, 2026 |
| David S. Wichmann | Director | 45,382 | 0.00% | May 11, 2026 |
| Cathy R. Smith | Director | 141 | 0.00% | May 11, 2026 |
| Jessica L. Mega | Director | 12,035 | 0.00% | May 11, 2026 |
| Ellen M. Zane | Director | 27,934 | 0.00% | May 11, 2026 |
| Yoshiaki Fujimori | Director | 2,081 | 0.00% | Jul 30, 2025 |
| John E. Sununu | Director | 54,723 | 0.00% | May 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Padraig Andrew O'Connor EVP, Global Operations | Sep 2, 2026 | Tax withholding | −567 | $48.37 | $27.43K | 7,892 |
| Padraig Andrew O'Connor EVP, Global Operations | Sep 2, 2026 | Option exercise | +1,171 | – | – | 8,459 |
| Susan E. Morano Director | Aug 25, 2026 | Buy | +2,040 | $49.22 | $100.41K | 13,784 |
| Emily Woodworth SVP, Global Controller and CAO | Aug 11, 2026 | Discretionary | +2,930 | $51.19 | $149.99K | 2,930 |
| Jonathan Monson EVP and CFO | Aug 10, 2026 | Discretionary | +9,908 | $50.46 | $499.96K | 9,908 |
| David C. Habiger Director | Aug 5, 2026 | Buy | +2,100 | $47.59 | $99.94K | 17,160 |
| David C. Habiger Director | Aug 4, 2026 | Buy | +140 | $48.59 | $6.80K | 15,060 |
| Michael F. Mahoney Chairman, President & CEO, Director | Aug 3, 2026 | Discretionary | +22,119 | $48.43 | $1.07M | 22,119 |
| Michael F. Mahoney Chairman, President & CEO, Director | Aug 3, 2026 | Buy | +186,240 | $48.33 | $9.00M | 1,590,024 |
| David C. Habiger Director | Aug 3, 2026 | Buy | +1,042 | $48.07 | $50.09K | 14,920 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Jul 31, 2026 | Discretionary | +64,198 | $46.73 | $3.00M | 64,198 |
| Edward J. Ludwig Director | Jul 31, 2026 | Buy | +5,000 | $45.48 | $227.40K | 30,359 |
| Jonathan Monson EVP and CFO | Jul 1, 2026 | Tax withholding | −1,010 | $43.06 | $43.49K | 39,063 |
| Jonathan Monson EVP and CFO | Jul 1, 2026 | Option exercise | +2,087 | – | – | 40,073 |
| Michael F. Mahoney Chairman, President & CEO, Director | May 28, 2026 | Gift | −386,755 | – | – | 0 |
| Cheryl Pegus Director | May 20, 2026 | Buy | +1,770 | $56.49 | $99.99K | 1,770 |
| David C. Habiger Director | May 20, 2026 | Buy | +2,250 | $55.92 | $125.82K | 13,878 |
| Edward J. Ludwig Director | May 20, 2026 | Buy | +3,580 | $56.68 | $202.91K | 25,359 |
| David C. Habiger Director | May 19, 2026 | Buy | +2,200 | $56.95 | $125.29K | 11,628 |
| Edward J. Ludwig Director | May 7, 2026 | Award | +3,800 | – | – | 21,779 |
| Christophe Pierre Weber Director | May 7, 2026 | Award | +1,767 | – | – | 2,646 |
| Christophe Pierre Weber Director | May 7, 2026 | Award | +1,140 | – | – | 3,786 |
| Susan E. Morano Director | May 7, 2026 | Award | +3,800 | – | – | 10,463 |
| Susan E. Morano Director | May 7, 2026 | Award | +1,281 | – | – | 11,744 |
| Ellen M. Zane Director | May 7, 2026 | Award | +3,800 | – | – | 27,934 |
| Jessica L. Mega Director | May 7, 2026 | Award | +3,800 | – | – | 12,035 |
| David S. Wichmann Director | May 7, 2026 | Award | +3,800 | – | – | 45,382 |
| David C. Habiger Director | May 7, 2026 | Award | +3,800 | – | – | 9,428 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | May 2, 2026 | Option exercise | +2,102 | – | – | 57,894 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | May 2, 2026 | Tax withholding | −1,007 | $56.50 | $56.90K | 56,887 |
| Padraig Andrew O'Connor EVP, Global Operations | May 2, 2026 | Option exercise | +1,802 | – | – | 7,896 |
| Padraig Andrew O'Connor EVP, Global Operations | May 2, 2026 | Tax withholding | −872 | $56.50 | $49.27K | 7,024 |
| Christophe Pierre Weber Director | Mar 2, 2026 | Award | +323 | – | – | 879 |
| Christophe Pierre Weber Director | Mar 2, 2026 | Award | +556 | – | – | 556 |
| Susan E. Morano Director | Mar 2, 2026 | Award | +24 | – | – | 6,663 |
| Emily Woodworth SVP, Global Controller and CAO | Mar 1, 2026 | Tax withholding | −372 | $76.85 | $28.59K | 2,859 |
| Emily Woodworth SVP, Global Controller and CAO | Mar 1, 2026 | Option exercise | +838 | – | – | 3,231 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 19, 2026 | Discretionary | +6,851 | $75.76 | $519.03K | 20,205 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 16, 2026 | Option exercise | +990 | – | – | 17,593 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 16, 2026 | Tax withholding | −291 | $74.73 | $21.75K | 17,302 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 16, 2026 | Option exercise | +905 | – | – | 6,433 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 16, 2026 | Tax withholding | −339 | $74.73 | $25.33K | 6,094 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 16, 2026 | Tax withholding | −283 | $74.73 | $21.15K | 2,393 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 16, 2026 | Option exercise | +637 | – | – | 2,676 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Feb 16, 2026 | Option exercise | +3,960 | – | – | 215,713 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Feb 16, 2026 | Tax withholding | −1,806 | $74.73 | $134.96K | 213,907 |
| Jonathan Monson EVP and CFO | Feb 16, 2026 | Option exercise | +990 | – | – | 38,426 |
| Jonathan Monson EVP and CFO | Feb 16, 2026 | Tax withholding | −440 | $74.73 | $32.88K | 37,986 |
| Michael F. Mahoney Chairman, President & CEO, Director | Feb 16, 2026 | Tax withholding | −7,865 | $74.73 | $587.75K | 1,576,860 |
| Michael F. Mahoney Chairman, President & CEO, Director | Feb 16, 2026 | Option exercise | +16,265 | – | – | 1,584,725 |
| Vance R. Brown EVP, GC and Corp. Secretary | Feb 16, 2026 | Option exercise | +1,839 | – | – | 55,134 |
| Vance R. Brown EVP, GC and Corp. Secretary | Feb 16, 2026 | Tax withholding | −890 | $74.73 | $66.51K | 54,244 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 16, 2026 | Tax withholding | −1,229 | $74.73 | $91.84K | 55,792 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 16, 2026 | Option exercise | +2,546 | – | – | 57,021 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 14, 2026 | Option exercise | +1,124 | – | – | 16,932 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 14, 2026 | Tax withholding | −329 | $74.73 | $24.59K | 16,603 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 14, 2026 | Option exercise | +1,190 | – | – | 5,977 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 14, 2026 | Tax withholding | −449 | $74.73 | $33.55K | 5,528 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 14, 2026 | Tax withholding | −296 | $74.73 | $22.12K | 2,039 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 14, 2026 | Option exercise | +661 | – | – | 2,335 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| F. Mahoney Michael Officer, Director | Feb 2, 2026 | 160,901 | $15.04M | Feb 2, 2026 | Performance Shares |
| C. Butcher Arthur Officer | Dec 1, 2025 | 17,313 | $1.76M | Dec 1, 2025 | Stock Option Exercise |
| Ellen M. Zane Director | Nov 6, 2025 | 2,901 | $284.17K | Nov 6, 2025 | stock grant |
| M. Fitzgerald Joseph Officer | Nov 3, 2025 | 50,000 | $4.97M | Nov 3, 2025 | Stock Option Exercise |
| Ellen M. Zane Director | Oct 28, 2025 | 2,901 | $296.59K | Oct 28, 2025 | Stock Grant |
| Ellen M. Zane Director | Oct 27, 2025 | 9,990 | $1.01M | Oct 27, 2025 | Stock Grant |
| M. Fitzgerald Joseph Officer | Oct 1, 2025 | 50,000 | $4.92M | Oct 1, 2025 | Stock Option Exercise |
| M. Fitzgerald Joseph Officer | Sep 2, 2025 | 50,000 | $5.27M | Sep 2, 2025 | Stock Option Exercise |
| M. Fitzgerald Joseph Officer | Aug 1, 2025 | 50,000 | $5.23M | Aug 1, 2025 | Stock Option Exercise |
| C. Butcher Arthur Officer | Aug 1, 2025 | 17,313 | $1.81M | Aug 1, 2025 | Stock Option Exercise |
| Fujimori Yoshiaki Director | Jul 29, 2025 | 2,901 | $310.38K | Jul 29, 2025 | Restricted Stock |
| Edward J. Ludwig Director | Jul 25, 2025 | 4,000 | $429.84K | Jul 25, 2025 | RSU Granted Shares |
| M. Fitzgerald Joseph Officer | Jul 1, 2025 | 50,000 | $5.35M | Jul 1, 2025 | Stock Option Exercise |
| M. Fitzgerald Joseph Officer | Jun 4, 2025 | 56,372 | $5.80M | Jun 4, 2025 | Stock Option Exercise |
| F. Mahoney Michael Officer, Director | Jun 2, 2025 | 164,443 | $17.05M | Jun 2, 2025 | Restricted Stock |